• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺叶切除术治疗支气管癌:合并症分析及其对术后发病率和死亡率的影响。

Lobectomy for treating bronchial carcinoma: analysis of comorbidities and their impact on postoperative morbidity and mortality.

作者信息

Sánchez Pablo Gerardo, Vendrame Giovani Schirmer, Madke Gabriel Ribeiro, Pilla Eduardo Sperb, Camargo José de Jesus Peixoto, Andrade Cristiano Feijó, Felicetti José Carlos, Cardoso Paulo Francisco Guerreiro

机构信息

Internal Medicine, Federal University of RioGrande do Sul, Porto Alegre, Brazil.

出版信息

J Bras Pneumol. 2006 Nov-Dec;32(6):495-504. doi: 10.1590/s1806-37132006000600005.

DOI:10.1590/s1806-37132006000600005
PMID:17435899
Abstract

OBJECTIVE

To analyze the impact that comorbidities have on the postoperative outcomes in patients submitted to lobectomy for the treatment of bronchial carcinoma.

METHODS

A retrospective study of 493 patients submitted to lobectomy for the treatment of bronchial carcinoma was conducted, and 305 of those patients met the criteria for inclusion in the final study sample. The surgical technique used was similar in all cases. The Torrington-Henderson scale and the Charlson scale were used to analyze comorbidities and to categorize patients into groups based on degree of risk for postoperative complications or death.

RESULTS

The postoperative (30-day) mortality rate was 2.9%, and the postoperative complications index was 44%. Prolonged air leakage was the most common complication (in 20.6%). The univariate analysis revealed that gender, age, smoking, neoadjuvant therapy and diabetes all had a significant impact on the incidence of complications. The factors found to be predictive of complications were body mass index (23.8 +/- 4.4), forced expiratory volume in one second (74.1 +/- 24%) and the ratio between forced expiratory volume in one second and forced vital capacity (0.65 +/- 0.1). The scales employed proved efficacious in the identification of the risk groups, as well as in drawing correlations with morbidity and mortality (p = 0.001 and p < 0.001). In the multivariate analysis, body mass index and the Charlson index were found to be the principal determinants of complications. In addition, prolonged air leakage was found to be the principal factor involved in mortality (p = 0.01).

CONCLUSION

Reductions in forced expiratory volume in one second, in the ratio between forced expiratory volume in one second and forced vital capacity, and in body mass index, as well as a Charlson score of 3 or 4 and a Torrington-Henderson score of 3, were associated with a greater number of postoperative complications in patients submitted to lobectomy for the treatment of bronchial carcinoma. Air leakage was found to be strongly associated with mortality.

摘要

目的

分析合并症对接受肺叶切除术治疗支气管癌患者术后结局的影响。

方法

对493例接受肺叶切除术治疗支气管癌的患者进行回顾性研究,其中305例患者符合纳入最终研究样本的标准。所有病例采用的手术技术相似。使用托灵顿 - 亨德森量表和查尔森量表分析合并症,并根据术后并发症或死亡风险程度将患者分组。

结果

术后(30天)死亡率为2.9%,术后并发症指数为44%。持续性漏气是最常见的并发症(20.6%)。单因素分析显示,性别、年龄、吸烟、新辅助治疗和糖尿病均对并发症发生率有显著影响。发现可预测并发症的因素为体重指数(23.8±4.4)、一秒用力呼气量(74.1±24%)以及一秒用力呼气量与用力肺活量之比(0.65±0.1)。所采用的量表在识别风险组以及与发病率和死亡率建立相关性方面被证明是有效的(p = 0.001和p < 0.001)。多因素分析中,体重指数和查尔森指数被发现是并发症的主要决定因素。此外,持续性漏气被发现是导致死亡的主要因素(p = 0.01)。

结论

对于接受肺叶切除术治疗支气管癌的患者,一秒用力呼气量、一秒用力呼气量与用力肺活量之比以及体重指数的降低,以及查尔森评分为3或4和托灵顿 - 亨德森评分为3,与更多的术后并发症相关。漏气被发现与死亡率密切相关。

相似文献

1
Lobectomy for treating bronchial carcinoma: analysis of comorbidities and their impact on postoperative morbidity and mortality.肺叶切除术治疗支气管癌:合并症分析及其对术后发病率和死亡率的影响。
J Bras Pneumol. 2006 Nov-Dec;32(6):495-504. doi: 10.1590/s1806-37132006000600005.
2
Exercise testing as a predictor of surgical risk after pneumonectomy for bronchogenic carcinoma.运动试验作为支气管源性肺癌肺切除术后手术风险的预测指标。
Respir Med. 2003 Dec;97(12):1296-8. doi: 10.1016/j.rmed.2003.07.004.
3
Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.在预计术后第 1 秒用力呼气量或一氧化碳弥散量低于正常的 40%的患者中,胸腔镜肺叶切除术与可接受的发病率和死亡率相关。
J Thorac Cardiovasc Surg. 2014 Jul;148(1):19-28, dicussion 28-29.e1. doi: 10.1016/j.jtcvs.2014.03.007. Epub 2014 Mar 13.
4
Pneumonectomy for malignant disease: factors affecting early morbidity and mortality.恶性疾病的肺切除术:影响早期发病率和死亡率的因素
J Thorac Cardiovasc Surg. 2001 Jun;121(6):1076-82. doi: 10.1067/mtc.2001.114350.
5
The influence of cardiopulmonary function on outcome of veterans undergoing resectional therapy for lung cancer.心肺功能对接受肺癌切除治疗的退伍军人预后的影响。
J Cardiovasc Surg (Torino). 1998 Aug;39(4):497-501.
6
Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma.局部复发性和第二原发性支气管源性癌的迭代手术切除
Eur J Cardiothorac Surg. 2000 Nov;18(5):529-34. doi: 10.1016/s1010-7940(00)00572-8.
7
Mortality of pulmonary resection for bronchial carcinoma.支气管癌肺切除术的死亡率。
J R Coll Surg Edinb. 1983 May;28(3):182-7.
8
[Is surgical therapy of bronchial carcinoma in advanced age justified?].
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:847-50.
9
The risk of death due to cardiorespiratory causes increases with time after right pneumonectomy: a propensity score-matched analysis.右全肺切除术后,因心肺原因导致的死亡风险随时间的推移而增加:倾向评分匹配分析。
Eur J Cardiothorac Surg. 2013 Jul;44(1):93-7. doi: 10.1093/ejcts/ezs620. Epub 2012 Dec 11.
10
Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy.袖状切除术伴未保护的支气管吻合术即使在新辅助治疗后也是安全的。
Eur J Cardiothorac Surg. 2012 Jul;42(1):77-81. doi: 10.1093/ejcts/ezr291. Epub 2012 Jan 20.

引用本文的文献

1
Management of Complications After Lung Resection: Prolonged Air Leak and Bronchopleural Fistula.肺切除术后并发症的处理:持续性漏气和支气管胸膜瘘。
Thorac Surg Clin. 2020 Aug;30(3):347-358. doi: 10.1016/j.thorsurg.2020.04.008. Epub 2020 Apr 17.
2
Lung cancer in Brazil.巴西的肺癌。
J Bras Pneumol. 2018 Jan-Feb;44(1):55-64. doi: 10.1590/S1806-37562017000000135.
3
Anatomic pulmonary resection by video-assisted thoracoscopy: the Brazilian experience (VATS Brazil study).电视辅助胸腔镜解剖性肺切除术:巴西经验(VATS 巴西研究)。
J Bras Pneumol. 2016 May-Jun;42(3):215-21. doi: 10.1590/S1806-37562015000000337.
4
The potential role of extracellular regulatory kinase in the survival of patients with early stage adenocarcinoma.细胞外调节激酶在早期腺癌患者生存中的潜在作用。
J Thorac Dis. 2014 Jul;6(7):930-6. doi: 10.3978/j.issn.2072-1439.2014.07.10.
5
Morbidity, mortality, and categorization of the risk of perioperative complications in lung cancer patients.肺癌患者围手术期并发症的发病率、死亡率和风险分类。
J Bras Pneumol. 2014 Jan-Feb;40(1):21-9. doi: 10.1590/S1806-37132014000100004.
6
The anticipation and management of air leaks and residual spaces post lung resection.肺切除术后空气泄漏和残余腔隙的预测与处理
J Thorac Dis. 2014 Mar;6(3):271-84. doi: 10.3978/j.issn.2072-1439.2013.11.29.
7
Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients.氧化还原状态失衡与肺腺癌患者的肿瘤侵袭性和不良预后相关。
J Cancer Res Clin Oncol. 2014 Mar;140(3):461-70. doi: 10.1007/s00432-014-1586-6. Epub 2014 Jan 22.
8
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating lung cancer recurrence.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在评估肺癌复发中的效能
J Bras Pneumol. 2013 Mar-Apr;39(2):242-4. doi: 10.1590/s1806-37132013000200017.
9
Non-small cell lung cancer in never smokers: a clinical entity to be identified.不吸烟人群中的非小细胞肺癌:一种有待鉴别的临床实体。
Clinics (Sao Paulo). 2011;66(11):1873-7. doi: 10.1590/s1807-59322011001100005.